Grant of Share Options

19th April 2024 - 10:35 am

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, announces the grant of unapproved share options over ordinary shares of 1 penny each to directors as follows.

Lisa Baderoon     3,000,000 share options (exercise price: 2.24p)

Laurence Reilly   2,000,000 share options (exercise price: 2.24p)

Share Option Period: All Share Options are valid for 10 years from the date of issue and will vest three years from the date of issue.

For full announcement download here

Share this article